Cargando…
Mobile health technology-supported atrial fibrillation screening and integrated care: A report from the mAFA-II trial Long-term Extension Cohort
Background. In the mobile Atrial Fibrillation App (mAFA)-II trial, the use of mobile health (mHealth) technology, incorporating AF screening and integrated management strategy, was associated with improved short-term clinical outcomes. The aim of this study was to report adherence/persistence and lo...
Autores principales: | Guo, Yutao, Guo, Jun, Shi, Xiangmin, Yao, Yuan, Sun, Yihong, Xia, Yunlong, Yu, Bo, Liu, Tong, Chen, Yundai, Lip, Gregory Y H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Federation of Internal Medicine. Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553102/ https://www.ncbi.nlm.nih.gov/pubmed/33067121 http://dx.doi.org/10.1016/j.ejim.2020.09.024 |
Ejemplares similares
-
Consumer-Led Screening for Atrial Fibrillation: A Report From the mAFA-II Trial Long-Term Extension Cohort
por: Guo, Yutao, et al.
Publicado: (2022) -
The Effects of Implementing a Mobile Health–Technology Supported Pathway on Atrial Fibrillation–Related Adverse Events Among Patients With Multimorbidity: The mAFA-II Randomized Clinical Trial
por: Yao, Yuan, et al.
Publicado: (2021) -
Mobile health-technology integrated care in secondary prevention atrial fibrillation patients: a post-hoc analysis from the mAFA-II randomized clinical trial
por: Guo, Yutao, et al.
Publicado: (2023) -
Efficacy of mobile health-technology integrated care based on the ‘Atrial fibrillation Better Care’ (ABC) pathway in relation to sex: a report from the mAFA-II randomized clinical trial
por: Guo, Yutao, et al.
Publicado: (2023) -
Mobile Health for Cardiovascular Disease: The New Frontier for AF Management: Observations from the Huawei Heart Study and mAFA-II Randomised Trial
por: Guo, Yutao, et al.
Publicado: (2020)